Hospices Struggle to Access Patients in Nursing Homes Amid Pandemic

With older adults suffering from chronic or life-limiting medical conditions among those most vulnerable during the COVID-19 outbreak, nursing homes across the country are restricting access to their facilities. As a result, hospice providers have experienced difficulty accessing their patients in nursing home settings. Nursing home populations are at the highest risk of being affected […]

Tailwinds May Shield Hospice Bottom Lines from Coronavirus Fallout

Despite recent hits on the overall markets, hospice company revenues may be protected by the growing demand for their services. The U.S. stock markets took a major blow due to turmoil stemming from volatile oil prices and the continuing economic impact of the global COVID 19 outbreak. Monday’s drop — the worse since 2008 — caused […]

VITAS Focused on Hospice De Novo, Same-Store Growth Over Acquisitions in 2020

Record-high valuations in the hospice mergers and acquisitions market are leading VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM), to target growth through de novos and same-store admissions rather than purchasing smaller hospices.  Multiples in the home care and hospice space reached as high as 26x EBITDA during 2019, the most significant rise for […]

VITAS Opens De Novo in San Antonio Region

Miami-headquartered hospice provider VITAS Healthcare has expanded its footprint in Texas with a new location in San Marcos, just outside of San Antonio. VITAS is a subsidiary of Chemed Corp. (NYSE: CHE). VITAS operates 48 hospice programs in 14 states, with a total average daily census of 19,137 as of the end of the third quarter […]

The Top 10 Largest Hospice Providers of 2019

Though the hospice space remains fragmented, mergers and acquisitions are driving up market share, particularly for large providers. Along with service diversification and application of emerging technologies, M&A is helping to drive growth among the organizations named in LexisNexis Top 100 Hospices of 2019. With 4.5% of market share, VITAS Healthcare, a subsidiary of Chemed […]

Rising Admissions Fuels Growth at VITAS Healthcare

VITAS Healthcare has seen substantial growth in same-store admissions during the third quarter of the year, boosting its revenues, according to financial results posted by the hospice provider’s parent company, Chemed Corp. (NYSE: CHE). VITAS admissions rose 4.4% from Q3 2018’s numbers to 17,131 patients. This is slightly stronger than the company’s second-quarter 2019 admissions […]

Hospice Industry Seeks Solutions to Issues in OIG Reports

Debate continues about how the hospice industry, as well as regulators, should respond to the reports on hospice care issued in July by the U.S. Department of Health and Human Services Office of the Inspector General (OIG) that included recommendations to the U.S. Centers for Medicare & Medicaid Services (CMS) on changing their processes for […]

Court: Difference of Opinion is Not Hospice Fraud

The Eleventh Circuit Court of Appeals partially affirmed a decision in favor of Arkansas-based hospice provider AseraCare in False Claims Act (FCA) case that has widespread implications for the hospice industry. The appellate court agreed with the Northern District of Alabama that a mere difference of physician’s opinions on a terminal patient’s prognosis does not […]

VITAS Expands Florida Operations to Treasure Coast Region

VITAS Healthcare, a hospice subsidiary of Chemed Corp. (NYSE: CHE), has received two certificates of need in Florida, signaling that the company is expanding its operations across a region known as the Treasure Coast. The Miami-based hospice provider will also build a new 16-bed freestanding inpatient facility in southwest Miami-Dade County. In addition to hospice […]

CMS Proposed Rule Could Hurt Small Hospice Providers, Large Companies Unfazed 

National and regional hospice chains seem unfazed by proposed Medicare payment rebasing for fiscal year 2020—confident that the updates will not adversely affect their businesses—though smaller organizations may take a more significant hit. The U.S. Centers for Medicare & Medicaid Services (CMS) in late April released its annual proposed rule that outlines the agency’s regulatory […]